Image for post
Image for post

There’s no well-stocked warehouse in the sky

Why timely contraceptive orders are critical, especially in these troubled times.

Last month, the RHSC’s Latin America and Caribbean Forum (ForoLAC) received a desperate call. A country in the region was nearly stocked out of two-rod contraceptive implants and needed 100,000 units urgently. The scramble that followed raised the curtain on an ominous reality: lead production times for many contraceptive products are at an all-time high.

Image for post
Image for post
General production times for a new Male Condom, Generic Implant and Emergency Contraception

The numbers are sobering. In a webinar ForoLAC hosted recently, UNFPA Procurement Specialist Mónica Lay levelled with those who had tuned in. Production time for a new generic implant is currently 32–36 weeks. Male condoms are taking four months to produce. Emergency contraception 12 months. And, this is before figuring in the time needed for administration, printing, packaging and transport, which could all add months to these already lengthy times.

The threat of extended waiting times should spur governments to get their orders in early, but that doesn’t seem to be the case. The business intelligence platform SEPREMI has recorded no government procurement of contraceptive products in any of the 15 Latin American and the Caribbean countries that contribute data to it. It is not uncommon, experts say, for countries to drag their feet till the last moment, placing urgent orders when the need becomes too large to ignore, after months of toying with the idea of completing an order. What many countries may not realize is that when they do place their orders, they may be in for a major shock.

As COVID-19 sneaked into 2020 and began to compromise supply chains everywhere, this situation continued to become increasingly tenuous. As public spending got rerouted into COVID-19 medications and personal protective equipment, new RH commodity procurement dwindled in many countries. Yes, with COVID-imposed curbs on movement and services, consumption has dwindled temporarily. But when demand grows again, unsuspecting countries stand to be rudely shocked by stockouts and growing unmet need.

Strictly speaking, this is not really breaking news. Supply constraints have been with us for more than a year and a half. Back in April 2019, the Coordinated Supply Planning group, now part of the Global FP VAN, issued a global statement, advising the RH community of critical production delays for Depo Provera-IM and the likely consequences for lead times and supply shortages. And for some time now, partners like UNFPA-PSB have published regular reminders urging countries to apply foresight and to purchase contraceptives strategically.

What can countries do?

The country in dire need mentioned at the start of this story went from pillar to post in a bid to secure supplies, and finally approached a commercial manufacturer who, fortunately, was able to provide emergency stock. They were lucky. But in times like these, luck can be thin on the ground.

It’s about supplies

Official blog of the Reproductive Health Supplies Coalition…

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store